SCHEMBL6762016

SCHEMBL6762016

O=C(O)CCC(=O)Nc1cc(Cl)cnc1OCC(=O)N1[C@@H]2CC[C@H]1CC(Oc1ccc(F)cc1)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.36
NAAA Q02083 1/20 0.36
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
SCN9A Q15858 2/20 0.35
EPHX2 P34913 5/20 0.35
HCRTR2 O43614 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGER2 P43116 1/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34
HTR7 P34969 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
HRH1 P35367 1/20 0.34
CCR3 P51677 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6762020 1.00 GPR119 (0.36) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6763123 0.90 GPR119 (0.37) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6763119 0.90 GPR119 (0.37) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6763114 0.88 CCR1 (0.40) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6763101 0.88 CCR1 (0.40) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6761297 0.82 HCRTR2 (0.40) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6761301 0.82 HCRTR2 (0.40) GPR119NAAAGRIN1GRIN2BSCN9A
SCHEMBL6760377 0.80 KCNH2 (0.40) NAAAGRIN1GRIN2BSCN9AEPHX2
SCHEMBL6760380 0.80 KCNH2 (0.40) NAAAGRIN1GRIN2BSCN9AEPHX2
SCHEMBL6761282 0.78 PTGER4 (0.40) GPR119NAAAGRIN1GRIN2BSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063688-A1 Novel piperidine derivatives PFIZER INC. 2004-04-01 US claimed
US-20040063688-A1 Novel piperidine derivatives PFIZER INC. 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063688-A1 Novel piperidine derivatives CCR1, CCR3, CCR2 GPR119 427/4885NAAA 4622/4885GRIN1 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.